Cargando…
The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion
To evaluate the prognosis of non-small cell lung cancer (NSCLC) patients according to endobronchial metastatic lesion (EML), especially those not identified on positron emission tomography or computed tomography. We evaluated progression-free survival (PFS) and overall survival (OS) according to the...
Autores principales: | Hong, Yoonki, Park, Sunmin, Lee, Myoung Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365769/ https://www.ncbi.nlm.nih.gov/pubmed/35948652 http://dx.doi.org/10.1038/s41598-022-17918-1 |
Ejemplares similares
-
Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non‐small‐cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2022) -
Differences in ICU Outcomes According to the Type of Anticancer Drug in Lung Cancer Patients
por: Hong, Yoonki, et al.
Publicado: (2022) -
Prognosis of multi‐level N2‐positive non‐small cell lung cancer according to lymph node staging using endobronchial ultrasound‐transbronchial biopsy
por: Yoon, Hee‐Young, et al.
Publicado: (2018) -
Non-secretory multiple myeloma expressed as multiple extramedullary plasmacytoma with an endobronchial lesion mimicking metastatic cancer: A case report
por: Lee, Seul Bi, et al.
Publicado: (2022) -
Endobronchial brachytherapy as definitive treatment for endobronchial metastasis after surgery of non-small cell lung cancer
por: Ito, Atsushi, et al.
Publicado: (2021)